Schedule 13D ownership disclosure
Amneal Pharmaceuticals Inc
Security class unavailable · CUSIP: 03168L105
Event date: 2018-05-04
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 12,150,947
- Percent of class
- 9.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-18-000274
- Form type
- SC 13D
- Filer
- Amneal Pharmaceuticals, Inc.
- CIK
- CIK 1723128
- Filed
- May 14, 2018
- Reporting period
- May 04, 2018
- Description
- Schedule 13D beneficial ownership